NAFDAC Orders Recall of Contaminated Amoxycillin Batch  

NAFDAC Orders Recall of Contaminated Amoxycillin Batch  
NAFDAC logo
The National Agency for Food and Drug Administration and Control (NAFDAC) has begun a recall of a specific batch of Deekins Amoxycillin 500mg Capsules due to reports of severe adverse reactions. 
The affected batch, identified as lot number 4C639001, was manufactured by Eco-med Pharma Ltd and distributed by DevineKings Pharmaceutical Ltd.
The recall decision came after a hospital reported three cases of serious reactions in patients who used this batch of the antibiotic.
Amoxycillin, commonly prescribed for bacterial infections such as sinusitis, pneumonia, and tonsillitis, is generally considered safe when used appropriately.
However, the reported incidents prompted immediate action to prevent further risks.
NAFDAC has urged consumers and healthcare providers to stop using the affected batch and report any related incidents.
 The public is advised to contact the nearest NAFDAC office for further guidance.
Subscribe to our newsletter for latest news and updates. You can disable anytime.
0 0 votes
Article Rating
Subscribe
Notify of
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments